Dong Ho Choi
Research Subjects
Dong Ho Choi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Hongmin Chu
Department of Internal Medicine Wonkwang University Gwangju Medical Center Gwangju Korea
1 shared publication- Hyung Won Kang
Department of Korean Neuropsychiatry Medicine, College of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea
1 shared publication Jongwon Jang
Department of Acupuncture and Moxibustion Medicine Wonkwang University Gwangju Medical Center Gwangju Korea
1 shared publication- Joonyoung Shin
Institute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea
1 shared publication - Ju-Hun Park
Haeundae Jaseng Hospital of Korean Medicine, Busan 48102, Korea
1 shared publication Kyungtae Park
Department of Rehabilitation Medicine of Korean Medicine Wonkwang University Gwangju Medical Center Gwangju Korea
1 shared publication
Latest Publications
- Open Access
- 31 May 2020
- Published by Korean Acupuncture and Moxibustion Medicine Society in Journal of Acupuncture Research
- Vol. 37 (2) , 110-117
Repeated-Dose Toxicity Testing of Scolopendrid Pharmacopuncture in Sprague-Dawley Rats
Background: The aim of this pilot study was to assess the safety and dosing of scolopendrid pharmacopuncture (SPP).Methods: A total of 40 healthy Sprague-Dawley rats (males and 20 females 20) were selected following a 7-day inspection and acclimation period. SPP was administered via intramuscular injection, over a 2-week period using 3 doses including a high-dose [0.84 mg of scolopendrid per kg of body weight (BW)], a meddose (0.42 mg/kg BW), and a low-dose (0.21 mg/kg BW). The control group was injected with sterile water into the muscles. Unusual changes caused by administration of the test substance were observed. Weight, feed intake, organ weight, and hematological examinations were compared among the groups. Using the SPSS statistical program, Levene’s test was performed to evaluate the homogeneity of variances, and a one-way ANOVA test was subsequently performed to assess the significance between each test group.Results: During the experiment no animals died. Weight change, food consumption, organ weight, hematological test, and blood biochemical tests showed no significant differences in the treatment groups compared to controls.Conclusion: No toxicological changes related to the administration of test substances were observed. Therefore, the LD50 (lethal-dose that kills 50%) of scolopendrid pharmacoupuncture in rats was greater than 0.84 mg/kg.
- 31 May 2020
- Published by Korean Acupuncture and Moxibustion Medicine Society in Journal of Acupuncture Research
- Vol. 37 (2) , 110-117
Open AccessRepeated-Dose Toxicity Testing of Scolopendrid Pharmacopuncture in Sprague-Dawley Rats
Background: The aim of this pilot study was to assess the safety and dosing of scolopendrid pharmacopuncture (SPP).Methods: A total of 40 healthy Sprague-Dawley rats (males and 20 females 20) were selected following a 7-day inspection and acclimation period. SPP was administered via intramuscular injection, over a 2-week period using 3 doses including a high-dose [0.84 mg of scolopendrid per kg of body weight (BW)], a meddose (0.42 mg/kg BW), and a low-dose (0.21 mg/kg BW). The control group was injected with sterile water into the muscles. Unusual changes caused by administration of the test substance were observed. Weight, feed intake, organ weight, and hematological examinations were compared among the groups. Using the SPSS statistical program, Levene’s test was performed to evaluate the homogeneity of variances, and a one-way ANOVA test was subsequently performed to assess the significance between each test group.Results: During the experiment no animals died. Weight change, food consumption, organ weight, hematological test, and blood biochemical tests showed no significant differences in the treatment groups compared to controls.Conclusion: No toxicological changes related to the administration of test substances were observed. Therefore, the LD50 (lethal-dose that kills 50%) of scolopendrid pharmacoupuncture in rats was greater than 0.84 mg/kg.